3PBIOVIAN
Lyon, France
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Plasmid DNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press10 articles
Manufacturing site information being gathered
Modalities: AAV, Plasmid DNA
Capacity assessment: 55.0/100
Recent News 10 articles
CDMOs Biovian and 3P eye global strategy through merger - BioProcess International
Biovian and 3P Combine to Establish 3PBiovian - Contract Pharma
Keensight’s Biovian, 3P Biopharmaceuticals merge to form pan-European biologics CDMO - pehub.com
3PBIOVIAN and INC partner to expand access to oncology treatments in Colombia through biosimilar development - European Biotechnology Magazine
Biovian and 3P Biopharmaceuticals Combine to Form 3PBIOVIAN - BioPharm International
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN - European Biotechnology Magazine
3PBIOVIAN - businessfocusmagazine.com
3PBIOVIAN Introduces Two Platforms for AAV and pDNA Manufacturing - Genetic Engineering and Biotechnology News
3PBIOVIAN partners Colombia cancer institute on biosimilar - The Pharma Letter
CDMO Roundup - Genetic Engineering and Biotechnology News
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: